Literature DB >> 15749850

Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane.

Francesca Giannoni1, Joellen Barnett, Kun Bi, Rodrigo Samodal, Paola Lanza, Patrizia Marchese, Rosario Billetta, Randi Vita, Mark R Klein, Berent Prakken, William W Kwok, Eli Sercarz, Amnon Altman, Salvatore Albani.   

Abstract

T cell activation is associated with active clustering of relevant molecules in membrane microdomains defined as the supramolecular activation cluster. The contact area between these regions on the surface of T cells and APC is defined as the immunological synapse. It has been recently shown that preclustering of MHC-peptide complexes in membrane microdomains on the APC surface affects the efficiency of immune synapse formation and the related T cell activation. Disruption of such clusters may reduce the efficiency of stimulation. We describe here an entirely artificial system for Ag-specific, ex vivo stimulation of human polyclonal T cells (artificial APC (aAPC)). aAPC are based on artificial membrane bilayers containing discrete membrane microdomains encompassing T cell ligands (i.e., appropriate MHC-peptide complexes in association with costimulatory molecules). We show here that preclustering of T cell ligands triggered a degree of T cell activation significantly higher than the one achieved when we used either soluble tetramers or aAPC in which MHC-peptide complexes were uniformly distributed within artificial bilayer membranes. This increased efficiency in stimulation was mirrored by increased translocation from the cytoplasm to the membrane of protein kinase theta, a T cell signaling molecule that colocalizes with the TCR within the supramolecular activation cluster, thus indicating efficient engagement of T cell activation pathways. Engineered aAPC may have immediate application for basic and clinical immunology studies pertaining to modulation of T cells ex vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749850     DOI: 10.4049/jimmunol.174.6.3204

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  From tango to quadrilla: current views of the immunological synapse.

Authors:  Cristina Mazzon; Antonella Viola
Journal:  Cell Adh Migr       Date:  2007-01-07       Impact factor: 3.405

Review 2.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

3.  RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.

Authors:  Qian Ding; Jian Chen; Xiaohui Wei; Wenqiang Sun; Junhua Mai; Yanzhu Yang; Yuhong Xu
Journal:  Pharm Res       Date:  2012-08-10       Impact factor: 4.200

Review 4.  Nanoengineering approaches to the design of artificial antigen-presenting cells.

Authors:  Joel C Sunshine; Jordan J Green
Journal:  Nanomedicine (Lond)       Date:  2013-07       Impact factor: 5.307

Review 5.  Nanoscale artificial antigen presenting cells for cancer immunotherapy.

Authors:  Kelly R Rhodes; Jordan J Green
Journal:  Mol Immunol       Date:  2018-03-07       Impact factor: 4.407

Review 6.  Biomimetic delivery with micro- and nanoparticles.

Authors:  Stephen C Balmert; Steven R Little
Journal:  Adv Mater       Date:  2012-04-23       Impact factor: 30.849

Review 7.  Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.

Authors:  Christian Schütz; Mathias Oelke; Jonathan P Schneck; Andreas Mackensen; Martin Fleck
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

8.  Cell-sized lipid vesicles for cell-cell synaptic therapies.

Authors:  D Vallejo; S H Lee; D Lee; C Zhang; C Rapier; S D Chessler; A P Lee
Journal:  Technology (Singap World Sci)       Date:  2018-01-24

Review 9.  Biomimetic particles as therapeutics.

Authors:  Randall A Meyer; Joel C Sunshine; Jordan J Green
Journal:  Trends Biotechnol       Date:  2015-08-12       Impact factor: 19.536

Review 10.  Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.

Authors:  Christopher D Spicer; Coline Jumeaux; Bakul Gupta; Molly M Stevens
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.